$0.91
-0.04 (-4.66%)
Performance
1D
—
1W
—
1M
—
3M
-20.88%
6M
-39.74%
1Y
-34.07%
YTD
-34.07%
Open$0.96
Previous Close$0.95
Day High$0.96
Day Low$0.89
52W High$3.79
52W Low$0.82
Volume—
Avg Volume3.92M
Market Cap264.47M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.26
Below
RSI (14)
38.1
Neutral
Analyst Ratings
Strong Buy
11 analysts
Price Target
+4,015.8% upside
Current
$0.91
$0.91
Target
$37.45
$37.45
$22.27
$37.45 avg
$46.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 268.06M | 287.87M | 65.59M |
| Net Income | -6,070,381 | -5,866,991 | -3,878,355 |
| Profit Margin | -2.3% | -2.2% | -5.9% |
| EBITDA | 26.67M | 27.21M | -4,128,349 |
| Free Cash Flow | — | — | -1,979,346 |
| Rev Growth | -6.9% | -6.9% | +11.6% |
| Debt/Equity | 5.94 | 5.94 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |